91AV

Introduction

Beilstein Talk

Nowadays, an emerging number of advanced therapies conquer the global market. Nanotechnology-related drug products show groundbreaking opportunities in cancer therapy. Still the translation of nanomedicines from bench to bedside poses a major challenge to the scientific community. The talk provides a snapshot of his research activities in the characterization of nanomedicines in vitro and in silico. Major hurdles in the development of novel drug delivery systems and their translation into the hospital will be discussed from the perspective of a pharmaceutical scientist

Useful links

Speakers

• Matthias G. Wacker National University of Singapore, Singapore

---

Venue

online, Germany

Organised by

Contact information

Dr. Michael Penk
Beilstein-Institut
Trakehner Str. 7–9
60487 Frankfurt am Main
Germany
+49 69 71673-224
Contact us by email

---